TNFα induces endothelial dysfunction in rheumatoid arthritis via LOX-1 and arginase 2: reversal by monoclonal TNFα antibodies
Alexander Akhmedov(University of Zurich), Thomas F. Lüscher(University of Zurich), Nicole R. Bonetti(University Hospital Zurich), Frank Ruschitzka(Kantonsspital St. Gallen), Mohammad Amrollahi‐Sharifabadi(University of Zurich), Matti Jauhiainen(Finnish Institute for Health and Welfare), Adrian Ciurea(University of Zurich), Rita Zilinyi(University of Debrecen), Margot Crucet(University of Zurich), Rose Cydecian(University of Zurich), Jari Metso(Minerva Foundation), Simon Kraler(University Hospital of Bern), Melroy Miranda(University of Zurich), Giovanni G. Camici(University of Zurich), Oliver Distler(University Hospital of Zurich), George Kollias(National and Kapodistrian University of Athens), Branko Simic(University of Zurich), Luca Liberale(Azienda Ospedaliera di Perugia), Reijo Laaksonen(Zora Biosciences (Finland)), Lena Schwarz(Life Science Zurich), Caroline Ospelt(University of Zurich), Lydia Ntari(Alexander Fleming Biomedical Sciences Research Center), Paul M. Vanhoutte(University of Hong Kong), Vera Fehr(University of Zurich), Niki Karagianni(Alexander Fleming Biomedical Sciences Research Center)
Cited by 31
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2018 ESC/ESH Guidelines for the management of arterial hypertension
|European Heart Journal|2018|10.5k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
|Annals of the Rheumatic Diseases|2017|1.6k